{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T17:20:26Z","timestamp":1780680026429,"version":"3.54.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T00:00:00Z","timestamp":1566172800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T00:00:00Z","timestamp":1566172800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Cardiovasc Drugs"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s40256-019-00368-y","type":"journal-article","created":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T02:02:38Z","timestamp":1566180158000},"page":"191-198","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Effects of Intracoronary Nicorandil on Myocardial Microcirculation and Clinical Outcomes in Patients with Acute Myocardial Infarction: A Meta-Analysis of Randomized Controlled Trials"],"prefix":"10.1007","volume":"20","author":[{"given":"Liye","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoxian","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5034-6067","authenticated-orcid":false,"given":"Shijie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,19]]},"reference":[{"key":"368_CR1","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/S0735-1097(00)00865-2","volume":"36","author":"I Morishima","year":"2000","unstructured":"Morishima I, Sone T, Okumura K, Tsuboi H, Kondo J, Mukawa H, Matsui H, Toki Y, Ito T, Hayakawa T. Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J Am Coll Cardiol. 2000;36:1202\u20139.","journal-title":"J Am Coll Cardiol."},{"key":"368_CR2","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jacc.2009.03.054","volume":"54","author":"G Niccoli","year":"2009","unstructured":"Niccoli G, Burzotta F, Galiuto L, Crea F. Myocardial no-reflow in humans. J Am Coll Cardiol. 2009;54:281\u201392.","journal-title":"J Am Coll Cardiol."},{"key":"368_CR3","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.amjcard.2011.09.037","volume":"109","author":"W Chan","year":"2012","unstructured":"Chan W, Stub D, Clark DJ, Ajani AE, Andrianopoulos N, Brennan AL, New G, Black A, Shaw JA, Reid CM, Dart AM, Duffy SJ. Usefulness of transient and persistent no reflow to predict adverse clinical outcomes following percutaneous coronary intervention. Am J Cardiol. 2012;109:478\u201385.","journal-title":"Am J Cardiol."},{"key":"368_CR4","doi-asserted-by":"publisher","first-page":"18J","DOI":"10.1016\/0002-9149(89)90200-2","volume":"63","author":"N Taira","year":"1989","unstructured":"Taira N. Nicorandil as a hybrid between nitrates and potassium channel activators. Am J Cardiol. 1989;63:18J\u201324J.","journal-title":"Am J Cardiol."},{"key":"368_CR5","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.12659\/MSM.902324","volume":"23","author":"Z Pang","year":"2017","unstructured":"Pang Z, Zhao W, Yao Z. Cardioprotective effects of nicorandil on coronary heart disease patients undergoing elective percutaneous coronary intervention. Med Sci Monit. 2017;23:2924\u201330.","journal-title":"Med Sci Monit."},{"key":"368_CR6","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/S0735-1097(98)00604-4","volume":"33","author":"H Ito","year":"1999","unstructured":"Ito H, Taniyama Y, Iwakura K, Nishikawa N, Masuyama T, Kuzuya T, Hori M, Higashino Y, Fujii K, Minamino T. Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction. J Am Coll Cardiol. 1999;33:654\u201360.","journal-title":"J Am Coll Cardiol."},{"key":"368_CR7","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/S0140-6736(02)08265-X","volume":"359","author":"Iona Study Group","year":"2002","unstructured":"Iona Study Group. Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial. Lancet. 2002;359:1269\u201375.","journal-title":"Lancet."},{"key":"368_CR8","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S0735-1097(99)00539-2","volume":"35","author":"T Matsubara","year":"2000","unstructured":"Matsubara T, Minatoguchi S, Matsuo H, Hayakawa K, Segawa T, Matsuno Y, Watanabe S, Arai M, Uno Y, Kawasaki M, Noda T, Takemura G, Nishigaki K, Fujiwara H. Three minute, but not one minute, ischemia and nicorandil have a preconditioning effect in patients with coronary artery disease. J Am Coll Cardiol. 2000;35:345\u201351.","journal-title":"J Am Coll Cardiol."},{"key":"368_CR9","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1159\/000051263","volume":"12","author":"M Oremus","year":"2001","unstructured":"Oremus M, Wolfson C, Perrault A, Demers L, Momoli F, Moride Y. Interrater reliability of the modified Jadad quality scale for systematic reviews of Alzheimer\u2019s disease drug trials. Dement Geriatr Cogn Disord. 2001;12:232\u20136.","journal-title":"Dement Geriatr Cogn Disord."},{"issue":"264\u20139","key":"368_CR10","first-page":"W64","volume":"151","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(264\u20139):W64.","journal-title":"Ann Intern Med."},{"key":"368_CR11","doi-asserted-by":"crossref","unstructured":"Higgins J, Green S. Cochrane handbook for systematic reviews of interventions. The Cochrane Collaboration 2008. \nhttp:\/\/www.cochrane-handbook.org\n\n. Accessed 1 Mar 2019.","DOI":"10.1002\/9780470712184"},{"key":"368_CR12","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.2307\/2533446","volume":"50","author":"CB Begg","year":"1994","unstructured":"Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088\u2013101.","journal-title":"Biometrics."},{"key":"368_CR13","first-page":"26","volume":"14","author":"C Feng","year":"2018","unstructured":"Feng C, Han B, Liu Y, Wang L, Niu D, Lou M, Lu C. Effect of nicorandil administration on myocardial microcirculation during primary percutaneous coronary intervention in patients with acute myocardial infarction. Postepy Kardiol Interwencyjnej. 2018;14:26\u201331.","journal-title":"Postepy Kardiol Interwencyjnej."},{"key":"368_CR14","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.hlc.2018.05.097","volume":"28","author":"C Feng","year":"2018","unstructured":"Feng C, Liu Y, Wang L, Niu D, Han B. Effects of early intracoronary administration of nicorandil during percutaneous coronary intervention in patients with acute myocardial infarction. Heart Lung Circ. 2018;28:858\u201365.","journal-title":"Heart Lung Circ"},{"key":"368_CR15","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.12659\/MSM.906815","volume":"24","author":"Q Qi","year":"2018","unstructured":"Qi Q, Niu J, Chen T, Yin H, Wang T, Jiang Z. Intracoronary nicorandil and the prevention of the no-reflow phenomenon during primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction. Med Sci Monit. 2018;24:2767\u201376.","journal-title":"Med Sci Monit."},{"key":"368_CR16","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.3892\/etm.2015.2623","volume":"10","author":"C Chen","year":"2015","unstructured":"Chen C, Fu X, Li W, Jia X, Bai S, Geng W, Xing K. Intracoronary administration of anisodamine and nicorandil in individuals undergoing primary percutaneous coronary intervention for acute inferior myocardial infarction: a randomized factorial trial. Exp Ther Med. 2015;10:1059\u201365.","journal-title":"Exp Ther Med."},{"key":"368_CR17","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1253\/circj.CJ-08-0212","volume":"72","author":"HC Lee","year":"2008","unstructured":"Lee HC, An SG, Choi JH, Lee TK, Kim J, Kim JH, Chun KJ, Hong TJ, Shin YW, Lee SK. Effect of intra-coronary nicorandil administration prior to reperfusion in acute ST segment elevation myocardial infarction. Circ J. 2008;72:1425\u20139.","journal-title":"Circ J."},{"key":"368_CR18","first-page":"211","volume":"2","author":"A Miyazawa","year":"2006","unstructured":"Miyazawa A, Ikari Y, Tanabe K, Nakajima H, Aoki J, Iijima R, Nakayama T, Hatori M, Nakazawa G, Tanimoto S, Onuma Y, Hara K. Intracoronary nicorandil prior to reperfusion in acute myocardial infarction. EuroIntervention. 2006;2:211\u20137.","journal-title":"EuroIntervention."},{"key":"368_CR19","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1253\/circj.70.1099","volume":"70","author":"S Ota","year":"2006","unstructured":"Ota S, Nishikawa H, Takeuchi M, Nakajima K, Nakamura T, Okamoto S, Setsuda M, Makino K, Yamakado T, Nakano T. Impact of nicorandil to prevent reperfusion injury in patients with acute myocardial infarction: Sigmart Multicenter Angioplasty Revascularization Trial (SMART). Circ J. 2006;70:1099\u2013104.","journal-title":"Circ J."},{"key":"368_CR20","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1253\/circj.68.192","volume":"68","author":"M Nameki","year":"2004","unstructured":"Nameki M, Ishibashi I, Miyazaki Y, Sakai Y, Namikawa S, Kuriyama N, Komiyama N, Tsunoda K, Masuda Y, Komuro I. Comparison between nicorandil and magnesium as an adjunct cardioprotective agent to percutaneous coronary intervention in acute anterior myocardial infarction. Circ J. 2004;68:192\u20137.","journal-title":"Circ J."},{"key":"368_CR21","first-page":"278","volume":"11","author":"O Muller","year":"2013","unstructured":"Muller O, Trana C, Eeckhout E. Myocardial no-reflow treatment. Curr Vasc Pharmacol. 2013;11:278\u201385.","journal-title":"Curr Vasc Pharmacol."},{"key":"368_CR22","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1161\/hc0502.102867","volume":"105","author":"SH Rezkalla","year":"2002","unstructured":"Rezkalla SH, Kloner RA. No-reflow phenomenon. Circulation. 2002;105:656\u201362.","journal-title":"Circulation."},{"key":"368_CR23","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1136\/heart.87.2.162","volume":"87","author":"T Reffelmann","year":"2002","unstructured":"Reffelmann T, Kloner RA. The \u201cno-reflow\u201d phenomenon: basic science and clinical correlates. Heart. 2002;87:162\u20138.","journal-title":"Heart."},{"key":"368_CR24","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1161\/01.CIR.89.6.2514","volume":"89","author":"RN Piana","year":"1994","unstructured":"Piana RN, Paik GY, Moscucci M, Cohen DJ, Gibson CM, Kugelmass AD, Carrozza JJ, Kuntz RE, Baim DS. Incidence and treatment of \u2018no-reflow\u2019 after percutaneous coronary intervention. Circulation. 1994;89:2514\u20138.","journal-title":"Circulation."},{"key":"368_CR25","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1097\/00005344-199510000-00006","volume":"26","author":"K Akai","year":"1995","unstructured":"Akai K, Wang Y, Sato K, Sekiguchi N, Sugimura A, Kumagai T, Komaru T, Kanatsuka H, Shirato K. Vasodilatory effect of nicorandil on coronary arterial microvessels: its dependency on vessel size and the involvement of the ATP-sensitive potassium channels. J Cardiovasc Pharmacol. 1995;26:541\u20137.","journal-title":"J Cardiovasc Pharmacol."},{"key":"368_CR26","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/S0735-1097(99)00552-5","volume":"35","author":"T Sato","year":"2000","unstructured":"Sato T, Sasaki N, O\u2019Rourke B, Marban E. Nicorandil, a potent cardioprotective agent, acts by opening mitochondrial ATP-dependent potassium channels. J Am Coll Cardiol. 2000;35:514\u20138.","journal-title":"J Am Coll Cardiol."},{"key":"368_CR27","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00380-010-0065-5","volume":"26","author":"R Kobatake","year":"2011","unstructured":"Kobatake R, Sato T, Fujiwara Y, Sunami H, Yoshioka R, Ikeda T, Saito H, Ujihira T. Comparison of the effects of nitroprusside versus nicorandil on the slow\/no-reflow phenomenon during coronary interventions for acute myocardial infarction. Heart Vessels. 2011;26:379\u201384.","journal-title":"Heart Vessels."},{"key":"368_CR28","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/hrt.2003.013789","volume":"90","author":"N Ikeda","year":"2004","unstructured":"Ikeda N, Yasu T, Kubo N, Hashimoto S, Tsuruya Y, Fujii M, Kawakami M, Saito M. Nicorandil versus isosorbide dinitrate as adjunctive treatment to direct balloon angioplasty in acute myocardial infarction. Heart. 2004;90:181\u20135.","journal-title":"Heart."},{"key":"368_CR29","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1161\/CIRCULATIONAHA.104.530329","volume":"112","author":"H Ishii","year":"2005","unstructured":"Ishii H, Ichimiya S, Kanashiro M, Amano T, Imai K, Murohara T, Matsubara T. Impact of a single intravenous administration of nicorandil before reperfusion in patients with ST-segment-elevation myocardial infarction. Circulation. 2005;112:1284\u20138.","journal-title":"Circulation."},{"key":"368_CR30","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/S0735-1097(01)01424-3","volume":"38","author":"S Hamada","year":"2001","unstructured":"Hamada S, Nishiue T, Nakamura S, Sugiura T, Kamihata H, Miyoshi H, Imuro Y, Iwasaka T. TIMI frame count immediately after primary coronary angioplasty as a predictor of functional recovery in patients with TIMI 3 reperfused acute myocardial infarction. J Am Coll Cardiol. 2001;38:666\u201371.","journal-title":"J Am Coll Cardiol."},{"key":"368_CR31","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1161\/01.CIR.101.2.125","volume":"101","author":"CM Gibson","year":"2000","unstructured":"Gibson CM, Cannon CP, Murphy SA, Ryan KA, Mesley R, Marble SJ, McCabe CH, Van De Werf F, Braunwald E. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation. 2000;101:125\u201330.","journal-title":"Circulation."},{"key":"368_CR32","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1161\/01.CIR.97.23.2302","volume":"97","author":"A van \u2019t Hof","year":"1998","unstructured":"van \u2019t Hof A, Liem A, Suryapranata H, Hoorntje JC, de Boer MJ, Zijlstra F. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group. Circulation. 1998;97:2302\u20136.","journal-title":"Circulation."},{"key":"368_CR33","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1016\/j.amjcard.2007.01.045","volume":"99","author":"I Porto","year":"2007","unstructured":"Porto I, Burzotta F, Brancati M, Trani C, Lombardo A, Romagnoli E, Niccoli G, Natale L, Bonomo L, Crea F. Relation of myocardial blush grade to microvascular perfusion and myocardial infarct size after primary or rescue percutaneous coronary intervention. Am J Cardiol. 2007;99:1671\u20133.","journal-title":"Am J Cardiol."},{"key":"368_CR34","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1093\/eurheartj\/ehi167","volume":"26","author":"P Sorajja","year":"2005","unstructured":"Sorajja P, Gersh BJ, Costantini C, McLaughlin MG, Zimetbaum P, Cox DA, Garcia E, Tcheng JE, Mehran R, Lansky AJ, Kandzari DE, Grines CL, Stone GW. Combined prognostic utility of ST-segment recovery and myocardial blush after primary percutaneous coronary intervention in acute myocardial infarction. Eur Heart J. 2005;26:667\u201374.","journal-title":"Eur Heart J."},{"key":"368_CR35","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0002-9149(99)00736-5","volume":"85","author":"JA de Lemos","year":"2000","unstructured":"de Lemos JA, Antman EM, Giugliano RP, McCabe CH, Murphy SA, Van de Werf F, Gibson CM, Braunwald E. ST-segment resolution and infarct-related artery patency and flow after thrombolytic therapy. Thrombolysis in Myocardial Infarction (TIMI) 14 investigators. Am J Cardiol. 2000;85:299\u2013304.","journal-title":"Am J Cardiol."}],"container-title":["American Journal of Cardiovascular Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-019-00368-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40256-019-00368-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-019-00368-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T00:06:42Z","timestamp":1597709202000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40256-019-00368-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,19]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["368"],"URL":"https:\/\/doi.org\/10.1007\/s40256-019-00368-y","relation":{},"ISSN":["1175-3277","1179-187X"],"issn-type":[{"value":"1175-3277","type":"print"},{"value":"1179-187X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,19]]},"assertion":[{"value":"19 August 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"No sources of funding were used to conduct this study or prepare this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Liye Shi, Ling Chen, Guoxian Qi, Wen Tian, and Shijie Zhao have no conflicts of interest that are directly relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}